BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35356653)

  • 1. Impact of new health care reform on enabling environment for children's health in China: An interrupted time-series study.
    Huangfu H; Zhang Z; Yu Q; Zhou Q; Shi P; Shen Q; Zhang Z; Chen Z; Pu C; Xu L; Hu Z; Ma A; Gong Z; Xu T; Wang P; Wang H; Hao C; Li C; Hao M
    J Glob Health; 2022; 12():11002. PubMed ID: 35356653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes of Multisectoral Collaboration and Service Delivery in Hypertension Prevention and Control before and after the 2009 New Healthcare Reform in China: An Interrupted Time-Series Study.
    Zhang Z; Hu Z; Wang H; Zhou Q; Li C; Hao M
    J Healthc Eng; 2021; 2021():8976625. PubMed ID: 34589192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Resources in Primary Health-Care Institutions before and after the New Health-Care Reform in China from 2003 to 2019: An Interrupted Time Series Analysis.
    Qin C; Liu M; Guo X; Liu J
    Int J Environ Res Public Health; 2022 May; 19(10):. PubMed ID: 35627589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of medical consortium policy on health services: an interrupted time-series analysis in Sanming, China.
    Yang X; Chen Y; Li C; Hao M
    Front Public Health; 2024; 12():1322949. PubMed ID: 38327577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding public health in China: an empirical analysis of healthcare inputs and outputs.
    Deng F; Lv JH; Wang HL; Gao JM; Zhou ZL
    Public Health; 2017 Jan; 142():73-84. PubMed ID: 28057203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does a new case-based payment system promote the construction of the ordered health delivery system? Evidence from a pilot city in China.
    Shi H; Cheng Z; Liu Z; Zhang Y; Zhang P
    Int J Equity Health; 2024 Mar; 23(1):55. PubMed ID: 38486230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What should the government do regarding health policy-making to develop community health care in Shanghai?
    Yu Y; Sun X; Zhuang Y; Dong X; Liu H; Jiang P; Yu Z; Zhang Y
    Int J Health Plann Manage; 2011; 26(4):379-435. PubMed ID: 22213259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of government investment in primary healthcare institutions to promote equity during the three-year health reform program in China.
    Zhang X; Xiong Y; Ye J; Deng Z; Zhang X
    BMC Health Serv Res; 2013 Mar; 13():114. PubMed ID: 23530658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficiency of provincial government health care expenditure after China's new health care reform.
    Guo X; Zhang J; Xu Z; Cong X; Zhu Z
    PLoS One; 2021; 16(10):e0258274. PubMed ID: 34644313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of pricing policy on the prices and supply of low-cost medicines in Shandong, China: evidence from an interrupted time series analysis.
    Rong X; Yin J; Duan S; Sun Q; Babar ZU
    BMC Public Health; 2020 Apr; 20(1):588. PubMed ID: 32349722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the National Centralized Drug Procurement Policy (4 + 7 policy) on the drug expenditures of patients treated in outpatient and emergency departments in a large tertiary level-A hospital in China: A single centre, interrupted time series.
    Lan T; Guan L; Pang X; Li X; Yu Q
    J Clin Pharm Ther; 2022 Jan; 47(1):104-111. PubMed ID: 34668203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in health expenditures in China in 2000s: has the health system reform improved affordability.
    Long Q; Xu L; Bekedam H; Tang S
    Int J Equity Health; 2013 Jun; 12():40. PubMed ID: 23764104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences of maternal mortality rate between Shanghai and New York city from the perspective of regulatory policy.
    Li L; Li CY; Zhou QY; Pu C; Xu LZ; Xu TQ; Hao C; Hu Z; Hao M
    Chin Med J (Engl); 2020 Apr; 133(7):792-799. PubMed ID: 32149767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Problems and challenges: development of blood transfusion services in Mainland China within the context of health-care system reform.
    Chen J; Ou-Yang J; Xie G; Liang H; Fan Y; Gao R; Li S; Rong X; He B; Bei C; Fu Y
    Transfus Med; 2019 Aug; 29(4):253-261. PubMed ID: 31359545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of inpatient distribution amongst different medical alliances in a county: a longitudinal study on a healthcare reform in rural China.
    Ran Y; Gao H; Han D; Hou G; Chen Y; Zhang Y
    Int J Equity Health; 2020 Aug; 19(1):142. PubMed ID: 32819362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assisted reproductive technology service availability, efficacy and safety in mainland China: 2016.
    Bai F; Wang DY; Fan YJ; Qiu J; Wang L; Dai Y; Song L
    Hum Reprod; 2020 Feb; 35(2):446-452. PubMed ID: 32020190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of the Full Coverage of Essential Medicines Policy on Utilization and Accessibility of Primary Healthcare Service for Rural Seniors: A Time Series Study in Qidong, China.
    Wang Y; Zhu Y; Shi H; Sun X; Chen N; Li X
    Int J Environ Res Public Health; 2019 Nov; 16(22):. PubMed ID: 31698773
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of DRGs-based inpatient service management on the performance of regional inpatient services in Shanghai, China: an interrupted time series study, 2013-2019.
    Feng L; Tian Y; He M; Tang J; Peng Y; Dong C; Xu W; Wang T; He J
    BMC Health Serv Res; 2020 Oct; 20(1):942. PubMed ID: 33046076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Chinese medical pricing reform on the structure of hospital revenue and healthcare expenditure in county hospital: an interrupted time series analysis.
    Liu M; Jia M; Lin Q; Zhu J; Wang D
    BMC Health Serv Res; 2021 Apr; 21(1):385. PubMed ID: 33902578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects on the medical revenue of comprehensive pricing reform in Chinese urban public hospitals after removing drug markups: case of Nanjing.
    Tang W; Xie J; Lu Y; Liu Q; Malone D; Ma A
    J Med Econ; 2018 Apr; 21(4):326-339. PubMed ID: 29139303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.